These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

326 related articles for article (PubMed ID: 19763296)

  • 1. A gorge-spanning, high-affinity cholinesterase inhibitor to explore beta-amyloid plaques.
    Elsinghorst PW; Härtig W; Goldhammer S; Grosche J; Gütschow M
    Org Biomol Chem; 2009 Oct; 7(19):3940-6. PubMed ID: 19763296
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vivo labelling of hippocampal beta-amyloid in triple-transgenic mice with a fluorescent acetylcholinesterase inhibitor released from nanoparticles.
    Härtig W; Kacza J; Paulke BR; Grosche J; Bauer U; Hoffmann A; Elsinghorst PW; Gütschow M
    Eur J Neurosci; 2010 Jan; 31(1):99-109. PubMed ID: 20092557
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vivo detection of amyloid-beta deposits by near-infrared imaging using an oxazine-derivative probe.
    Hintersteiner M; Enz A; Frey P; Jaton AL; Kinzy W; Kneuer R; Neumann U; Rudin M; Staufenbiel M; Stoeckli M; Wiederhold KH; Gremlich HU
    Nat Biotechnol; 2005 May; 23(5):577-83. PubMed ID: 15834405
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Styryl-based compounds as potential in vivo imaging agents for beta-amyloid plaques.
    Li Q; Min J; Ahn YH; Namm J; Kim EM; Lui R; Kim HY; Ji Y; Wu H; Wisniewski T; Chang YT
    Chembiochem; 2007 Sep; 8(14):1679-87. PubMed ID: 17705341
    [TBL] [Abstract][Full Text] [Related]  

  • 5. X-34 labeling of abnormal protein aggregates during the progression of Alzheimer's disease.
    Ikonomovic MD; Abrahamson EE; Isanski BA; Debnath ML; Mathis CA; Dekosky ST; Klunk WE
    Methods Enzymol; 2006; 412():123-44. PubMed ID: 17046656
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel benzofuran derivatives for PET imaging of beta-amyloid plaques in Alzheimer's disease brains.
    Ono M; Kawashima H; Nonaka A; Kawai T; Haratake M; Mori H; Kung MP; Kung HF; Saji H; Nakayama M
    J Med Chem; 2006 May; 49(9):2725-30. PubMed ID: 16640332
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Amyloid-cholinesterase interactions. Implications for Alzheimer's disease.
    Inestrosa NC; Dinamarca MC; Alvarez A
    FEBS J; 2008 Feb; 275(4):625-32. PubMed ID: 18205831
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rivastigmine is a potent inhibitor of acetyl- and butyrylcholinesterase in Alzheimer's plaques and tangles.
    Eskander MF; Nagykery NG; Leung EY; Khelghati B; Geula C
    Brain Res; 2005 Oct; 1060(1-2):144-52. PubMed ID: 16212945
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gangliosides determine the amyloid pathology of Alzheimer's disease.
    Oikawa N; Yamaguchi H; Ogino K; Taki T; Yuyama K; Yamamoto N; Shin RW; Furukawa K; Yanagisawa K
    Neuroreport; 2009 Aug; 20(12):1043-6. PubMed ID: 19590389
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis and biological evaluation of radioiodinated 2,5-diphenyl-1,3,4-oxadiazoles for detecting beta-amyloid plaques in the brain.
    Watanabe H; Ono M; Ikeoka R; Haratake M; Saji H; Nakayama M
    Bioorg Med Chem; 2009 Sep; 17(17):6402-6. PubMed ID: 19651517
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reduction of Alzheimer's disease amyloid plaque load in transgenic mice by D3, A D-enantiomeric peptide identified by mirror image phage display.
    van Groen T; Wiesehan K; Funke SA; Kadish I; Nagel-Steger L; Willbold D
    ChemMedChem; 2008 Dec; 3(12):1848-52. PubMed ID: 19016284
    [No Abstract]   [Full Text] [Related]  

  • 12. Potent beta-amyloid modulators.
    García-Palomero E; Muñoz P; Usan P; Garcia P; Delgado E; De Austria C; Valenzuela R; Rubio L; Medina M; Martínez A
    Neurodegener Dis; 2008; 5(3-4):153-6. PubMed ID: 18322376
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bringing amyloid into focus.
    Golde TE; Bacskai BJ
    Nat Biotechnol; 2005 May; 23(5):552-4. PubMed ID: 15877070
    [No Abstract]   [Full Text] [Related]  

  • 14. In silico modeling of the specific inhibitory potential of thiophene-2,3-dihydro-1,5-benzothiazepine against BChE in the formation of beta-amyloid plaques associated with Alzheimer's disease.
    Ul-Haq Z; Khan W; Kalsoom S; Ansari FL
    Theor Biol Med Model; 2010 Jun; 7():22. PubMed ID: 20550720
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Therapy of Alzheimer disease].
    Kovács T
    Neuropsychopharmacol Hung; 2009 Mar; 11(1):27-33. PubMed ID: 19731816
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 11C-labelled PIB analogues as potential tracer agents for in vivo imaging of amyloid beta in Alzheimer's disease.
    Serdons K; Verduyckt T; Vanderghinste D; Borghgraef P; Cleynhens J; Van Leuven F; Kung H; Bormans G; Verbruggen A
    Eur J Med Chem; 2009 Apr; 44(4):1415-26. PubMed ID: 18992967
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tacripyrines, the first tacrine-dihydropyridine hybrids, as multitarget-directed ligands for the treatment of Alzheimer's disease.
    Marco-Contelles J; León R; de los Ríos C; Samadi A; Bartolini M; Andrisano V; Huertas O; Barril X; Luque FJ; Rodríguez-Franco MI; López B; López MG; García AG; Carreiras Mdo C; Villarroya M
    J Med Chem; 2009 May; 52(9):2724-32. PubMed ID: 19374444
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chemical and pharmacological studies on enantiomerically pure p-methoxytacripyrines, promising multi-target-directed ligands for the treatment of Alzheimer's disease.
    Bartolini M; Pistolozzi M; Andrisano V; Egea J; López MG; Iriepa I; Moraleda I; Gálvez E; Marco-Contelles J; Samadi A
    ChemMedChem; 2011 Nov; 6(11):1990-7. PubMed ID: 21990269
    [No Abstract]   [Full Text] [Related]  

  • 19. Molecular basis of interactions of cholinesterases with tight binding inhibitors.
    Radić Z; Manetsch R; Krasiński A; Raushel J; Yamauchi J; Garcia C; Kolb H; Sharpless KB; Taylor P
    Chem Biol Interact; 2005 Dec; 157-158():133-41. PubMed ID: 16289416
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Propidium-based polyamine ligands as potent inhibitors of acetylcholinesterase and acetylcholinesterase-induced amyloid-beta aggregation.
    Bolognesi ML; Andrisano V; Bartolini M; Banzi R; Melchiorre C
    J Med Chem; 2005 Jan; 48(1):24-7. PubMed ID: 15633997
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.